News

Insulet (Nasdaq:PODD) announced today that its board of directors appointed Ashley McEvoy as president and CEO, effective ...
Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...
Medtronic announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...
Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.
Abbott says the new Libre app provides a simplified view of data patterns, enabling FreeStyle Libre CGM users to better understand the impact of food, activity, and insulin on glucose levels. [Image ...
The MiniMed 780G automated insulin delivery system with the Simplera Sync CGM. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose ...